Ginkgo biloba - Adverse effects
Research News and Information

Saturday, November 21, 2009

Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers.

26 Apr 2009 BACKGROUND: Ginkgo biloba extract (GBE), the best selling herbal medicine in the world, has been reported to inhibit P-glycoprotein in vitro. However, the effects of GBE on P-glycoprotein activity in humans have not been clarified. OBJECTIVE: To ... Read more...

Four common herbs seen in dental practice: properties and potential adverse effects.

30 Mar 2009 The use of herbal supplements in North America is steadily growing and raises concerns about safety, efficacy, and how they affect safe patient care. The most notable and direct health risks associated with herbal supplements include hypertension, ... Read more...

Perioperative risks and benefits of herbal supplements in aesthetic surgery.

27 Feb 2009 Most medications, herbal preparations, and nutraceutical supplements have notable effects on biochemical pathways and may influence wound healing, coagulation, and cardiovascular function. They can also interact with other drugs. A large portion of ... Read more...

Latest indexed articles for 'Ginkgo biloba - Adverse effects'

These are the very latest articles for this heading:

• Interaction of Ginkgo biloba with efavirenz. 30 May 2009
• Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers. 26 Apr 2009
• Four common herbs seen in dental practice: properties and potential adverse effects. 30 Mar 2009
• Perioperative risks and benefits of herbal supplements in aesthetic surgery. 27 Feb 2009
• Can ginkgo biloba combat diseases? 27 Feb 2009
• Ginkgo might not be a brain saver. 27 Feb 2009
• Drug therapy in Alzheimer disease: an update for the oral health care provider. 29 Sep 2008
• Potential interaction of Ginkgo biloba leaf with antiplatelet or anticoagulant drugs: what is the evidence? 29 Jun 2008
• A systematic review of natural health product treatment for vitiligo. 20 May 2008
• Application of FDA adverse event report data to the surveillance of dietary botanical supplements. 6 Apr 2008
• Herb-drug interactions. 30 Jan 2008
• Haemorrhage due to Ginkgo biloba? 30 Jan 2008
• Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects. 30 Jan 2008
• Herbal therapies and cardiac side effects. 30 Dec 2007
• [Life-threatening hyponatremia provoked by alternative treatment. An occurrence in a patient with chronic lymphocytic leukemia with no indication for treatment] 8 Dec 2007
• The effect of herbal medicines on platelet function: an in vivo experiment and review of the literature. 29 Nov 2007
• Ginkgo and Alzheimer's disease: little or no different from placebo. 29 Sep 2007
• Association between priapism and concurrent use of risperidone and Ginkgo biloba. 29 Sep 2007
• Application regarding ginkgo biloba. 30 Aug 2007
• An examination of the bleeding complications associated with herbal supplements, antiplatelet and anticoagulant medications. 29 Jun 2007

See a longer list of these articles.

Technical information about 'Ginkgo biloba'

Definition: The only specie of the genus Ginkgo, family Ginkgoacea. It is the source of extracts of medicinal interest, especially Egb 761. Ginkgo may refer to the genus or species.

Descriptor UI: D020441

Alternative terms: Ginkgo biloba; Ginko; Gingko biloba; Ginkgo; Maidenhair Tree; Gingko; Ginkgophyta;

Allowable Qualifiers: adverse effects; anatomy & histology; classification; cytology; drug effects; embryology; enzymology; genetics; growth & development; immunology; metabolism; microbiology; parasitology; physiology; poisoning; radiation effects; toxicity; ultrastructure; chemistry; virology;

Tree Number: B06.388.400.300;

History Note: 99; for GINKGOPHYTA see GYMNOSPERMS 1998

Technical Notes: coord with specific PLANT COMPONENTS term if pertinent; for use in therapy coord IM with PHYTOTHERAPY (IM) + disease/drug ther (IM) + PLANT PREPARATION or its indentations/ther use (IM or NIM) + specific plant chemical /ther use (IM) if pertinent; Manual 26.29